The Interleukin Inhibitors Market is estimated to be valued at USD 36.60 Bn in 2024 and is expected to exhibit a CAGR of 12.6% over the forecast period 2024- 2031, as highlighted in a new report published by Coherent Market Insights. The increasing prevalence of cancer and autoimmune diseases is expected to drive the growth of the Read More…
